1. Daldrup-Link, H. E., Rudelius, M., Piontek, G., Metz, S., Brauer, R., Debus, G., Corot, C., Schlegel, J., Link, T. M., Peschel, C., et al. (2005).
Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment.
Radiology 234, 197-205.

2. Daldrup-Link, H. E., Meier, R., Rudelius, M., Piontek, G., Piert, M., Metz, S., Settles, M., Uherek, C., Wels, W., Schlegel, J., and Rummeny, E. J. (2005).
In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging.
Eur Radiol 15, 4-13.

3. Daldrup-Link, H. E., Rudelius, M., Metz, S., Piontek, G., Pichler, B., Settles, M., Heinzmann, U., Schlegel, J., Oostendorp, R. A., and Rummeny, E. J. (2004).
Cell tracking with gadophrin-2: a bifunctional contrast agent for MR imaging, optical imaging, and fluorescence microscopy.
Eur J Nucl Med Mol Imaging 31, 1312-1321.

4. Kappler, R., Hess, I., Schlegel, J., and Hahn, H. (2004).
Transcriptional up-regulation of Gadd45a in Patched-associated medulloblastoma.
Int J Oncol 25, 113-120.

5. Nieder, C., Grosu, A. L., Grzadziel, A., Schlegel, J., and Molls, M. (2004).
Brain metastases in renal cell cancer: diagnostic and therapeutic aspects.
Am J Clin Oncol 27, 632-634.

6. Schlegel, J., Neff, F., and Piontek, G. (2004).
Serial induction of mutations by ethylnitrosourea in PC12 cells: a new model for a phenotypical characterization of the neurotoxic response to 6-hydroxydopamine.
J Neurosci Methods 137, 215-220.

7. Theodoropoulou, M., Arzberger, T., Gruebler, Y., Jaffrain-Rea, M. L., Schlegel, J., Schaaf, L., Petrangeli, E., Losa, M., Stalla, G. K., and Pagotto, U. (2004).
Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells.
J Endocrinol 183, 385-394.

8. Rellecke, P., Kuchelmeister, K., Schachenmayr, W., Schlegel, J (2004)
Mismatch repair protein hMSH2 in primary drug resistance in in vitro human malignant gliomas.
J Neurosurg 101: 653-658

9. Lu L., Neff, F., Dun, Z., Hemmer, B., Oertel, W: H., Schlegel, J., Hartmann, A. (2004)
Gene expression profiles derived from single cells in human postmortem brain.
Brain Res. Protoc. 13: 18-25

10. Hafezparast, M., Klocke, R., Ruhrberg, C., Marquardt, A., Ahmad-Annuar, A., Bowen, S., Lalli, G., Witherden, A.S., Hummerich, H., Nicholson, S.,Morgan, P.J., Oozageer, R., Priestley, J.V., Averill, S., King, V.R., Ball, S., Peters, J., Toda, T., Yamamoto, A., Korthaus, D., Augustin, M., Wattler, S., Wabnitz, P., Dickneite, C., Lampel, S., Peraus, G., Popp, A., Rudelius, M., Schlegel, J., et al. (2003)
Mutations in Dynein Link Motor Neuron Degeneration to Defects in Retrograde Transport.
Science 300: 808-812

11. Daldrup-Link, H.E., Rudelius, M., Oostendorp, R.A.J., Settles, M., Piontek, G., Metz, S., Heinzmann, U., Rummeny, E.J., Schlegel, J., Link, T.M. (2003)
Targeting of Hematopoietic Progenitor Cells with MR Contrast Agents.
Radiology 228: 760-767

12. Rudelius, M., Daldrup-Link, H.E., Heinzmann, U., Piontek, G., Settles, M., Link, T.M., Schlegel, J. (2003)
Highly efficient paramagnetic cellular labeling of neuronal stem cells
Eur. J. Nucl. Med. Mol. Imaging. 30: 1038-1044

13. Kappler, R., Calzada-Wack, J., Schnitzbauer, U., Piontek, P., Graedler, F., Adamski, J., Heinzmann, U., Schlegel, J., Quintanilla-Martinez, L., Hahn, H. (2003)
Molecular characterisation of Patched-associated rhabdomyosarcoma
J. Pathol. 200: 348-356

14. Bacher, M., Schrader, J., Thompson, N., Kuschela, K., Gemsa, D., Waeber, G., Schlegel, J. (2003)
Up-Regulation of Macrophage Migration Inhibitory Factor Gene and Protein Expression in Glial Tumor Cells during Hypoxic and Hypoglycemic Stress Indicates a Critical Role for Angiogenesis in Glioblastoma Multiforme
Am. J. Pathol. 162: 11-17

15. Schlegel J., Durchschlag, G., Piontek, G., Grosu, A. L. (2002)
Activation of the phosphatidylinositol-3’-kinase/protein kinase B-dependent anti-apoptotic pathway plays an important role in the development of radioresistance in human glioma cells
Ann. N. Y. Acad. Sci. 973: 224-227

16. Schlegel, J, Güneysu, S., Mennel, H.-D. (2002)
Expression of Methyl-Binding Domain (MBD) containing proteins in human gliomas
Oncol. Rep. 9: 393-395

17. Schlegel, J, Piontek, G., Mennel, H.-D. (2002)
Activation of Akt/protein kinase B correlates with EGF receptor overexpression in human malignant glioma biopsies
Anticancer Res. 22: 2837-40

18. Neff, F., Noelker, C., Eggert, K., Schlegel, J. (2002)
Signalling pathways mediate the neuroprotective effects of GDNF
Ann. N. Y. Acad. Sci. 973: 70-74

19. Neff, F., Eggert, K, Schlegel, J (2002)
Phosphorylation and inactivation of Bad by GDNF-activated protein kinase B/Akt in human neuroblastoma cells
Neurosci. Res. Comm. 30: 167-172

20. Schnabel, M., Marlovits, S., Eckhoff, G., Fichtel, I., Gotzen, L., Vécsei, V., Schlegel, J. (2002)
Differentiation-associated changes in morphology and gene expression in primary human articular chondrocytes in cell culture
Osteoarthritis and Cartilage 10: 62-70

21. Schnabel M., Fichtel I., Gotzen L., Schlegel J. (2002)
Differential expression of Notch genes in human osteoblastic cells.
Int. J. Mol. Med. 9: 229-232.

22. Kraus, A.C., Ferber, I., Bachmann, S.O., Specht, H., Wimmel, H., Gross, M.W., Schlegel, J., Suske, G., Schuermann, M. (2002)
In vitro chemo- and radio-resistance in small cell lung cancer correlates with cell adhesion and constitutive activation of Akt and MAP kinase pathways
Oncogene 21: 8683-8695

23. Fuchs, M., Hutzler, P., Brunner, I., Schlegel, J., Mages, J., Reuning, U., Hapke, S., Hirohashi, S., Genda, T., Sakamato, M., Überall, F., Höfler, H., Becker, K-F., Luber, B. (2002)
Motility enhancement by tumor-derived mutant e-cadherin is sensitive to treatment with epidermal growth factor receptor and phosphatidylinositol 3-kinase inhibitors
Exp. Cell Res. 276: 129-141

24. Kroiss, M.M., Vogt, T., Schlegel, J., Landthaler, M., Stolz, W. (2001)
Increased Frequency of Microsatellite Instability in Advanced Stages of Malignant Melanomas
Acta Derm. Venerol. 81: 242-245

25. Brockhoff G., Heiss P., Schlegel J., Hofstaedter F., Knuechel R. (2001)
Epidermal-Growth-Factor-Receptor, c-erbB2, and c-erbB3 receptor interaction and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells
Cytometry 44: 338-348

26. Sure, U., Butz, N., Schlegel, J., Siegel, A., Wakat, J.P., Mennel, H.D., Bien, S., Bertalanffy, H. (2001)
Endothelial proliferation and neoangiogenesis, and potential de novo generation of cerebral vascular malformations
J. Neurosurg. 94:972-977

27. Schlegel, J., Budde, B., Neff, F., Piontek, G., Kraus, A.. (2000)
The Akt/protein kinase B-dependent anti-apoptotic pathway and the mitogen activated protein kinase cascade are alternatively activated in human glioblastoma multiforme
Cancer Lett 158: 103-108

28. Kraus, A., Gross, M., Knüchel, R., Münkel, K., Neff, F., Schlegel, J. (2000)
Aberrant p21 regulation in radioresistant primary glioblastoma cells bearing wild-type p53
J. Neurosurg. 93: 863-872